Psiquiatria Biologica最新文献

英文中文

Importancia de indagar sobre salud mental en embarazadas en controles gestacionales habituales

Q4 Medicine

Psiquiatria Biologica

Pub Date : 2024-12-01 DOI: 10.1016/j.psiq.2024.100557

Mirta Olga Solis Correa, Sara Jiménez Fernández, Mercedes Valverde Barea

Pregnancy and the transition to motherhood involve important psychological and social changes in the mother, which have been related to the presence of anxiety and depression symptoms. Therefore, the aim of this study is to investigate aspects of mental health in pregnant patients, which could help in the early detection of mood pathologies, anxiety and suicidal behaviors. The results show that only a small number of pregnant women have been addressed in relation to their mental health in routine maternity controls, overlooking moderate/severe depression/anxiety, and even self-harming ideations. The mandatory regular visits for the control of pregnant women in both primary care and hospital care are a good opportunity to inquire about possible mood disorders, presence of anxious symptoms and suicidal ideation in this patient population, with the possibility of referral to the Emergency Department or Mental Health specialists, or simply to follow up these patients more closely.

引用次数: 0

Metacognition vulnerabilities in time of crisis: Who to protect from suicidal risk?

Q4 Medicine

Psiquiatria Biologica

Pub Date : 2024-12-01 DOI: 10.1016/j.psiq.2024.100553

Sylvia Martin, Anna Oltra, Jonathan Del Monte

During the COVID-19 pandemic, we could try to avoid negative information processing and anxiogenic content to prevent unhealthy thinking processes. One of the processes we can observe regarding our way of thinking is metacognition. The objective of this study is to look at its possible impact on suicide risk in the clinical and non-clinical populations. The results showed that the COVID 19 crisis influenced metacognitive levels for the non-clinical sample but not for the clinical population. Moreover, hopelessness predicted suicide risk for both populations, but metacognition was also a predictive factor for the non-clinical sample. In conclusion, the possible impact of preventive measures based on metacognitive work that can be created out of these results is presented.

引用次数: 0

Trastorno por tics y trastorno obsesivo compulsivo: Trastornos neuropsiquiátricos pediátricos autoinmunes asociados a infecciones por estreptococos (PANDAS) y enfermedades psiquiátricas en niños y adolescentes

Q4 Medicine

Psiquiatria Biologica

Pub Date : 2024-12-01 DOI: 10.1016/j.psiq.2024.100554

Hilario Blasco-Fontecilla, Victor del Rio-Peña, Ping Wang, Chao Li, Marina Martin-Moratinos, Marcos Bella-Fernández

PANDAS syndrome (Pediatric Autoimmune Neuropsychiatric Disorders associated with Streptococcal infections) is associated with different neuropsychiatric disorders, such as tic disorders and obsessive-compulsive disorder (OCD). This study of 801 children and adolescents compares the socio-demographic, clinical and academic functioning profile of ASLO-positive patients with that of ASLO-negative or non-ASLO-positive patients. The results indicate that ASLO-positive patients are seven times more likely to have tics and OCD, as well as a higher frequency of Emergency Department admissions and a higher prevalence of trauma or fractures. However, no association between ASLO positivity and attention deficit hyperactivity disorder (ADHD) or academic functioning is found.

引用次数: 0

Influencia de la ketamina en el abordaje y control de la ideación suicida en adultos con depresión mayor e impacto a nivel cognitivo

Q4 Medicine

Psiquiatria Biologica

Pub Date : 2024-12-01 DOI: 10.1016/j.psiq.2024.100556

Luz Maria González Gualda, María Aliño Dies, Nora Inés Muros Cobos, Juan del Águila Águila, Ruben Roig Cremades, Javier Bajen Espuña

In this work, a review of the literature is carried out to analyze the influence of ketamine in the approach and control of suicidal ideation, as well as in the impact at the cognitive level, among adult patients (over 20 years of age) diagnosed with major depression. The results show that ketamine has been shown to be an effective strategy in the control of treatment-resistant depression and suicidal ideation, acting acutely in situations of adult patients of all ages with major depression. Although the analysis of the impact on the cognitive functioning of patients has identified deleterious and temporary alterations within the first hours after ketamine administration, in the long term, improvements in the cognitive function of patients are identified. Reduced anxiety, improved mood and better functioning are identified after ketamine treatment. A reduction in suicidal ideation and in the severity of depressive symptomatology is also observed.

引用次数: 0

Hemidistonía como efecto adverso de neurolépticos: A propósito de un caso clínico

Q4 Medicine

Psiquiatria Biologica

Pub Date : 2024-12-01 DOI: 10.1016/j.psiq.2024.100558

Sheila Cruz Bailén, Fermín González Higueras, Mirta Olga Solís

Tardive dyskinesias are persistent abnormal movements, occasionally irreversible, that appear during prolonged use of neuroleptics. It is presented the case of a 21-year-old male under follow-up in Mental Health since 2013 with a diagnosis of schizophrenia and on neuroleptic treatment since the age of 13. Two years ago he began to present orolingual dyskinesia and steppage gait; medication was reduced, but no clinical improvement was found. The patient was being treated with aripiprazole and paliperidone, which was reduced due to the appearance of extrapyramidalism, and he was switched to monotherapy with paliperidone depot. In the last months, lurasidone was introduced and depot was discontinued, persisting with gait and speech difficulties. Finally, a diagnosis of hemidystonia secondary to drugs was made. No improvement has been found with muscle relaxants or any of the drugs used and local botulinum toxin and deep brain stimulation have been proposed. The adverse effects of neuroleptics can be expressed with a wide variety of clinical manifestations and are difficult to reverse. In conclusion, prevention by monitoring symptoms every 6–12 months and assessing the risk–benefit of these drugs is important.

{"title":"Hemidistonía como efecto adverso de neurolépticos: A propósito de un caso clínico","authors":"Sheila Cruz Bailén, Fermín González Higueras, Mirta Olga Solís","doi":"10.1016/j.psiq.2024.100558","DOIUrl":"10.1016/j.psiq.2024.100558","url":null,"abstract":"<div><div>Tardive dyskinesias are persistent abnormal movements, occasionally irreversible, that appear during prolonged use of neuroleptics. It is presented the case of a 21-year-old male under follow-up in Mental Health since 2013 with a diagnosis of schizophrenia and on neuroleptic treatment since the age of 13. Two years ago he began to present orolingual dyskinesia and steppage gait; medication was reduced, but no clinical improvement was found. The patient was being treated with aripiprazole and paliperidone, which was reduced due to the appearance of extrapyramidalism, and he was switched to monotherapy with paliperidone depot. In the last months, lurasidone was introduced and depot was discontinued, persisting with gait and speech difficulties. Finally, a diagnosis of hemidystonia secondary to drugs was made. No improvement has been found with muscle relaxants or any of the drugs used and local botulinum toxin and deep brain stimulation have been proposed. The adverse effects of neuroleptics can be expressed with a wide variety of clinical manifestations and are difficult to reverse. In conclusion, prevention by monitoring symptoms every 6–12 months and assessing the risk–benefit of these drugs is important.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":"31 ","pages":"Article 100558"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143103993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

XIII Encuentros Nacionales en Psiquiatría. Un foro de comunicación para expertos en conducta suicida y jóvenes investigadores

Q4 Medicine

Psiquiatria Biologica

Pub Date : 2024-12-01 DOI: 10.1016/j.psiq.2024.100687

María José Jaén Moreno , María José Moreno Díaz

引用次数: 0

Conducta suicida en interconsulta: Comparación entre pacientes mayores y menores de 65 años

Q4 Medicine

Psiquiatria Biologica

Pub Date : 2024-12-01 DOI: 10.1016/j.psiq.2024.100552

Jesús Ángel Monforte Porto, Alberto de Vega Martín, Marisol Asperilla Gallardo

The aim of this study is to determine the sociodemographic, clinical and health care characteristics of the demands for suicidal ideation/attempt in relation to the elderly population versus those under 65 years of age in psychiatric interconsultation. The results show that the mean length of stay is longer in the older population. Regarding discharge referral, admissions to psychiatric hospitalization units predominated in the younger population, as well as referral to mental health facilities. In the population over 65 years of age, referral to primary care facilities and higher mortality predominate.

引用次数: 0

Consumo de sustancias ilícitas y suicidio consumado desde una perspectiva de género

Q4 Medicine

Psiquiatria Biologica

Pub Date : 2024-12-01 DOI: 10.1016/j.psiq.2024.100555

Miguel Zacarías Pérez Sosa, Diego de la Vega Sánchez

The literature indicates that being female, smoking tobacco, having a history of physical and sexual abuse, suffering from depression, and alcohol and cannabis use are associated with suicidal ideation. If cocaine, amphetamines and/or multiple substance abuse are also consumed, there is a significant association with suicide attempts. However, there are few studies that analyze substance use in women who die by suicide. Although different studies relate substance use to completed suicide in women, especially alcohol use, it is debated whether the presence of other psychiatric disorders, in addition to substance use, could partially explain the associations between substance use and suicide in women; therefore, the aim of this study is to investigate whether the use of the main illicit substances is a risk factor for death by completed suicide in women. In this sample of women, the use of major illicit substances does not appear to be a risk factor for completed suicide.

引用次数: 0

Decoding a case of pica: The path to a difficult diagnosis

Q4 Medicine

Psiquiatria Biologica

Pub Date : 2024-11-30 DOI: 10.1016/j.psiq.2024.100550

Ignacio Ramos Suárez , Margarita Guerrero Jiménez

Pica, a disorder characterized by the ingestion of non-food substances, is typically associated with psychiatric conditions but can also indicate underlying neurological disorders.

This report, details the case of a 61-year-old woman with a history of histrionic personality disorder and generalized anxiety disorder who developed severe pica, ingesting objects such as screws and jewelry. Initial psychiatric evaluations did not reveal a clear explanation for her behavior. However, further investigation identified significant cognitive decline, gait disturbances, and urinary incontinence—symptoms indicative of adult chronic hydrocephalus (ACH). A cranial CT scan confirmed ventricular dilation, leading to an ACH diagnosis. Pica disorder is often linked to frontal lobe dysfunction, common in ACH.

This case emphasizes the necessity of interdisciplinary collaboration between psychiatry and neurology to ensure accurate diagnosis and effective treatment, improving outcomes for patients whose psychiatric symptoms may mask an underlying neurological condition.

引用次数: 0

Huntington latente desenmascarado por aripiprazol

Q4 Medicine

Psiquiatria Biologica

Pub Date : 2024-11-26 DOI: 10.1016/j.psiq.2024.100549

Elena Blanco-Martin, Maria Nieto-Compán, Jorge López-Álvarez

Huntington's disease is an inherited neurodegenerative disorder whose symptoms include movement disorders, cognitive impairment, and psychiatric symptoms, and usually appear between the ages of 30 and 50. We present the case of a 31-year-old woman admitted to Psychiatry for the first time due to a depressive episode with suicidal ideation. Previously evaluated by Neurology without a clear diagnosis, due to movement alterations, stereotypies and motor incoordination. The presence of motor symptoms during admission led to an interconsultation with the Neurology Department. Extrapyramidal syndrome was diagnosed and Huntington's disease was suspected, later confirmed by genetic studies. After adjusting the medication and eliminating aripiprazole, depressive and motor symptoms improved. This case highlights the importance of considering neurodegenerative diseases when psychiatric, motor, and cognitive symptoms are present simultaneously. In addition, it shows how the side effects of drugs can unmask latent diseases.

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Psiquiatria Biologica

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀